In a mouse model of PDA, Clec7a deletion significantly reduced the infiltration of PDA with F4/80+, CD206+ and Arg1+ TAMs, as well as upregulated MHCII, TNF-α and iNOS expression in tumor (46). This evidence concerns the gene CLEC7A and Patent ductus arteriosus.